GLP-1 medications work with the hormone your body already uses to signal fullness. Prescribed after a full medical assessment, monitored throughout, and matched to the option that suits you.
GLP-1 receptor agonists represent the most significant shift in weight management medicine in decades. They work by mimicking glucagon-like peptide-1, a hormone your gut releases after eating that tells your brain you've had enough and slows how quickly your stomach empties. For many people the effect isn't willpower-adjacent at all.
Food simply stops occupying the same mental space. There are two main options, and they aren't interchangeable. Semaglutide targets the GLP-1 receptor alone. Tirzepatide is a dual agonist, acting on both GLP-1 and GIP receptors. Which is appropriate depends on your health history, tolerance, and goals — that's a clinical decision, not a preference.
1
Targets appetite at the hormonal level
Rather than relying on restriction alone, GLP-1 medications amplify your body's natural satiety signaling — addressing hunger and food preoccupation directly.
2
Two options, matched to you
Semaglutide and tirzepatide work through different mechanisms. We'll assess which is clinically appropriate rather than defaulting to whichever is most talked about.
3
Supervised from labs to follow-up
Medical assessment before you start, gradual dose titration, and scheduled reviews throughout. Side effects get managed, not tolerated in silence.
Choosing a treatment shouldn't feel like guesswork. Here's what most people ask before their first visit — and if your question isn't here, just ask us.
GLP-1 is a hormone your intestines release after eating. GLP-1 receptor agonists are prescription medications that mimic it — signaling fullness to the brain, slowing gastric emptying, and helping regulate blood sugar.
Semaglutide acts on the GLP-1 receptor. Tirzepatide is a dual agonist, acting on GLP-1 and GIP receptors simultaneously. They have different dosing schedules and side effect profiles, and suitability depends on your individual health picture.
Through medical assessment and lab work. We'll review your health history, current medications, and bloodwork. These medications aren't appropriate for everyone — certain thyroid and pancreatic histories are contraindications — and we'll go through this fully before anything is prescribed.
Gastrointestinal effects are the most common: nausea, constipation, or digestive discomfort, typically strongest in early weeks and after each dose increase. Gradual titration is designed specifically to limit this. Less common but serious risks will be discussed in full before you begin.
GLP-1 therapy is a tool, not a cure. Appetite regulation generally returns to baseline once the medication stops, which is why we pair treatment with nutrition and lifestyle support — the habits built during therapy are what carry the results forward. Duration is reviewed with you rather than fixed in advance.
